Sinemet cr and Mobility decreased - a phase IV clinical study of FDA data

Summary:

Mobility decreased is reported as a side effect among people who take Sinemet cr (carbidopa; levodopa), especially for people who are male, 60+ old, have been taking the drug for 10+ years also take Movicol, and have Abnormal faeces.

The phase IV clinical study analyzes which people have Mobility decreased when taking Sinemet cr. It is created by eHealthMe based on reports of 2,682 people who have side effects when taking Sinemet cr from the FDA, and is updated regularly.

What is Sinemet cr?

Sinemet cr has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 2,852 Sinemet cr users. Check the latest studies of Sinemet cr.

What is Mobility decreased?

Mobility decreased (ability to move is reduced) is found to be associated with 1,776 drugs and 1,636 conditions by eHealthMe. Check the latest studies of Mobility decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

2,682 people reported to have side effects when taking Sinemet cr.
Among them, 145 people (5.41%) have Mobility decreased.

Could Sinemet cr cause Mobility decreased?

Among these 145 people:

How long have people been on Sinemet cr when they have Mobility decreased? *

Click here to view more results

What is the gender of people who have Mobility decreased when taking Sinemet cr? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Sinemet cr and have Mobility decreased?

- Check whether Mobility decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sinemet cr:

Sinemet cr (2,852 reports)

Mobility decreased treatments and more:

Mobility decreased (83,538 reports)

How severe was Mobility decreased and when was it recovered:

Mobility decreased in Sinemet cr

Expand to all the drugs that have ingredients of carbidopa; levodopa:

Mobility decreased and drugs with ingredients of carbidopa; levodopa (208 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sinemet cr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mobility decreased:

Mobility decreased (1,776 drugs)

Browse all the conditions that are associated with Mobility decreased:

Mobility decreased (1,636 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carbidopa; levodopa (the active ingredients of Sinemet cr) and Sinemet cr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.